Puneet Wadhwa
 "Puneet Wadhwa")
Puneet Wadhwa
Puneet Wadhwa leads all stock & financial markets’ coverage at Business Standard. He has an experience of over two decades in managing India’s busiest print, digital and electronic newsrooms at the Outlook Group, NDTV and Hindustan Times.
Puneet Wadhwa leads all stock & financial markets’ coverage at Business Standard. He has an experience of over two decades in managing India’s busiest print, digital and electronic newsrooms at the Outlook Group, NDTV and Hindustan Times.
Page 100 - Puneet Wadhwa
Good time to buy beaten-down shares, say analysts
One out of five stocks from the BSE-500 index has underperformed in 2014
 "Good time to buy beaten-down shares, say analysts")
View on India can change significantly if the poll mandate is highly fractured: Mark McFarland
Interview with Global Chief Economist, Coutts
 "View on India can change significantly if the poll mandate is highly fractured: Mark McFarland")
Which way will the market swing on May 16?
Give some thought to stocks you pick and your appetite for risk as observers are unsure if the market will go up or down
 "Which way will the market swing on May 16?")
Govt's disinvestment programme shall be back on track: Pranav Haldea
Interview with Managing Director, Prime Database
Realty shares crack; analysts advise caution
A rational view suggests that one should take an investment call in these stocks post the election outcome rather than taking the plunge now
 "Realty shares crack; analysts advise caution")
Expect a sectoral churn in favour of cyclicals: Harshad Patwardhan
Interview with Executive Director & Head of Equities, JPMorgan Asset Management
 "Expect a sectoral churn in favour of cyclicals: Harshad Patwardhan")
Manic May: Should you sell stocks or wait it out?
The month is traditionally lean worldwide, so much so that fund managers prefer to go on vacation than trade. But the air of expectancy around the election outcome has kept things heated
 "Manic May: Should you sell stocks or wait it out?")
Analysts expect revival in primary markets
Assume a stable govt at the Centre after the polls, which does not delay actions that can boost the economy; even so, investors should be choosy, say experts
 "Analysts expect revival in primary markets")
Oil & gas stocks flare; index hits 3-yr high
Reliance Industries has rallied 3% to Rs 989, its highest level since April 2011
 "Oil & gas stocks flare; index hits 3-yr high")
Capital goods scrips rally on FII buying
L&T, BHEL, AIA Engineering and Pipavav Defence from the capital goods space rallied 4% each on the BSE.
 "Capital goods scrips rally on FII buying")
FIIs bullish on ICICI Bank; stake hits 6-year high
During quarter ended March, the stock gains 13.3% compared with the Bankex's 12% rise
 "FIIs bullish on ICICI Bank; stake hits 6-year high")
Rate-sensitive stocks see heavy selling
In another negative, IIP for February contracted 1.9% led by a dismal show in manufacturing, especially capital goods
 "Rate-sensitive stocks see heavy selling")
Infy's guidance looks conservative, say analysts
Bangalore-based Infosys surprised the Street with a 4.1% q-o-q rise in its net profit for the fourth quarter ended March 2014 at Rs 2,992 crore
 "Infy's guidance looks conservative, say analysts")
Will Infy's FY14 numbers surprise analysts?
Here is what the brokerages expect the company to report while announcing its Q4FY14 and full year FY14 results on Tuesday
 "Will Infy's FY14 numbers surprise analysts?")
176 BSE 500 stocks rally over 50% since August
Of these 176 stocks, 52 scrips have rallied over 100%
 "176 BSE 500 stocks rally over 50% since August")
Can the next finance minister address market concerns?
The onus of framing and implementation of reform-oriented policies will be in the Finance Ministry
 "Can the next finance minister address market concerns?")
'Implementation would be the nub'
However, say market watchers, implementation would be the nub
 "'Implementation would be the nub'")
Pharma gets a US shot in arm
Wockhardt's plants in Waluj, Chikalthana and Nani Daman are under the FDA scanner, with products from these banned in the US
 "Pharma gets a US shot in arm")
Worst may be behind US-based companies: George Russell
Interview with Institutional Portfolio Manager, Franklin Equity Group
 "Worst may be behind US-based companies: George Russell")
 "BS Bank Aspirex performs in line with BSE Bankex")